AAE	Adversarial autoencoder
AEs	Autoencoders
AMP	Antimicrobial peptide
ANNs	Artificial neural networks
CADD	Computer-aided drug design
CBP	CREB-binding protein
CNNs	Convolutional neural networks
D-MPNN	Direct-message-passing neural network
DB	Database
DDIs	Drug–Drug Interactions
DDR1	Discoidin domain receptor1
DDNs	Drug–Disease Networks
DSENs	Drug–Side effect Networks
DTIs	Drug–target interactions
FDA	Food and drug administration
GANs	Generative adversarial networks
GAT	Graph attention network
GCNs	Graph convolutional networks
GNN	Graph neural network
GPCR	G-protein coupled receptor
GPU	Graphical processing units
GRU	Gated recurrent units
GVAE	Grammar variational autoencoder
HTS	High-throughput screening
IC50	Half-maximum inhibitory concentration
LSTM	Long short-term memory
MAE	Mean absolute error
MTDNN	Multitask deep neural network
NLP	Natural language processing
NNs	Neural networks
ORGAN	Objective-Reinforced Generative Adversarial Networks
ORGANIC	Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry
PPIs	Protein–Protein Interactions
PRISMA	Preferred reporting items for systematic review and meta-analyses
PUNs	Pretrained unsupervised networks
QSAR	Quantitative Structure–Activity Relationships
RANC	Reinforced adversarial neural computer
ReLU	Rectified linear unit
RL	Reinforcement Learning
RNNs	Recurrent neural networks
ROC-AUC	Receiver operating characteristic curve-area under curve
ROR-γt	Retinoic-acid-receptor related orphan receptor-gamma t
SMILES	Simplified molecular input line entry system
SOM	Self-organizing map
TL	Transfer Learning
TTD	Therapeutic Target DB
VAE	Variational autoencoder
WAE	Wasserstein autoencoder